Search
Pennant Group Inc
PNTGAdd to Watchlist
38.520USD
+1.160+3.10%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.33BMarket Cap
44.00P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Pennant Group Inc is 9.14, ranking 2 out of 75 in the Healthcare Providers & Services industry. The average price target is 35.50, with a high of 39.00 and a low of 30.00.
Analyst Rating
Based on
7
analysts
Strong Buy
Current Rating
40.833
Target Price
+12.36%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Pennant Group Inc
PNTG
7
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Pennant Group Inc's expected revenue for the next quarter?
Pennant Group Inc's expected revenue is 288.62M.
What is Pennant Group Inc's price target?
Analysts forecast that Pennant Group Inc's price target is USD 35.50, with the highest forecast at USD 39.00 and the lowest forecast at USD 30.00.
How have Pennant Group IncPNTG's recent earnings per share performed?
The market expectation was USD 0.25, while Pennant Group IncPNTG's earnings per share (EPS) for the previous quarter was USD 0.25. EPS for the next quarter is expected at USD 0.33.
What is the analyst rating for Pennant Group Inc?
Based on the ratings of Pennant Group Inc's stock from 7 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.